ACM
JAZZ icon

Aubrey Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Aubrey Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,847
Closed -$227K – 69
2023
Q4 		$227K Hold
1,847
– – 0.1% 60
2023
Q3 		$226K Hold
1,847
– – 0.13% 53
2023
Q2 		$229K Hold
1,847
– – 0.15% 48
2023
Q1 		$270K Hold
1,847
– – 0.16% 43
2022
Q4 		$294K Hold
1,847
– – 0.24% 39
2022
Q3 		$246K Hold
1,847
– – 0.21% 39
2022
Q2 		$288K Hold
1,847
– – 0.23% 43
2022
Q1 		$288K Sell
1,847
-700
-27% -$102K 0.16% 56
2021
Q4 		$324K Buy
2,547
+250
+11% +$32.9K 0.13% 35
2021
Q3 		$299K Sell
2,297
-508
-18% -$76.8K 0.09% 36
2021
Q2 		$498K Hold
2,805
– – 0.15% 31
2021
Q1 		$461K Buy
+2,805
New +$462K 0.13% 35

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.22B AUM 26.01% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return